News Contact Us

$2.5 Bn by 2024| Direct-to-Consumer (DTC) Genetic Testing Market To Amass Huge Share

Author : Rahul Sankrityayan | Published Date : 2019-03-14 

The global direct-to-consumer genetic testing market is touted to emerge as one of the most lucrative business verticals of the healthcare space in the years ahead. One of the most principal reasons for the same is the customer’s growing demand for DTC genetic tests like carrier screenings and the growing trend surrounding ancestry testing. In fact, one of the top trends the market witnessed in 2018 was the surging number of customers who opted a DNA test for the holiday season.

In December 2018, an article by the Chicago Tribune reported how testing companies have been advertising DNA kits as holiday gifts leading to numerous customers investing in one that literally needs nothing more than a spit sample to pinpoint one’s heritage and other genetic details. This Christmassy trend helped several genetic testing companies like Ancestry, which secured a robust database from over 7 million people.

Request for a sample of this research report @ www.gminsights.com/request-sample/detail/3033

Among a slew of DTC tests that exist, some of them reveal one’s ancestry by continent and country, while some help users find relatives by identifying other users with similar DNA. However, one of the most useful features of the test is its ability to reveal medical conditions, an inclination toward a disease, or other traits. The rising occurrences of diseases that are genetically inherited are one of the key factors driving the global direct-to-consumer genetic testing market industry growth. Rare and genetic diseases often times boast uncommon symptoms representing a huge medical challenge to doctors. Numbers by Global Genes unveiled that there are roughly 7,000 kinds of rare and genetic disorders, with more being discovered every day.

The United States hosts 30 million people suffering from rare diseases, which accounts for 10% of the U.S. population. Similarly, Europe has nearly 30 million people with a rare disease. Moreover, it is projected that 350 million people suffer from rare diseases globally, so much that if all the affected people were gathered in one country, it would make for the world’s third-most populated nation. The figures further stated that 80% of rare diseases are caused by faulty genes and therefore present throughout a person’s life. 

Owing to the aforementioned trends, it is rather overt that the adoption of technologies like DTC predictive testing which offer data regarding the likelihood of someone acquiring a certain disease will increase. This would substantially propel DTC genetic testing market size from predictive testing, that stood at a valuation of $110.8 million in 2017.

Carrier test types – also known as carrier screenings is another technology that’s been on the popularity radar lately. Couples mostly opt for carrier testing before or during pregnancy to identify whether they are at risk of passing genetic disorders to their children. As per the Center for Disease Control and Prevention, birth defects are the leading reason for infant mortality, equaling 20% of all infant deaths. The growing need to control infant mortality rate by determining the risks of a newborn inheriting any genetic disorders will drive DTC genetic testing market from carrier testing in the years to come.

It is however, prudent to mention that carrier testing has presented some obstacles for individuals who are uncertain of their ethnic backgrounds. Such challenges can be prevented through expanded carrier screening, a more advanced version of the available test that can identify disease-causing mutations regardless of a patient’s ethnicity. It is thus quite vivid, that advancements in this domain are also slated to boost the momentum of carrier testing in the years ahead.

Make an inquiry for purchasing this report @ www.gminsights.com/inquiry-before-buying/3033

DTC testing is often thought to be meant solely for humans, however, the technology has even managed to attract pet owners worldwide. Case in point, the California-based startup Basepaws, the first company offering DTC genetic testing for cats, focuses on delivering comprehensive data concerning breed information and health insights. In this time and age, people are extremely conscious about their pet’s health. Getting a genetic test can help pet owners detect the traits connected health conditions like obesity or heart disease. In addition, it helps save time and money on trial and error to identify the best foods for certain breeds.

The expansion of DTC testing from humans to animals is also a strong factor that can fuel direct-to-consumer genetic testing market growth in the years to come. Aided by the human curiosity concerning the exploration of one’s legacy, DTC genetic testing market size is anticipated to surpass $2.5 billion by 2024, according to data compiled by Global Market Insights, Inc.  

About Author

Rahul Sankrityayan

Rahul Sankrityayan

Fortified with a post-graduate degree in Computer Applications, Rahul Sankrityan writes for Fractovia, where he pens down news and articles spanning across segments of technology industry that excite him on a day-to-day basis. Rahul comes with a rich experience in technical field as well as writing. He can be contacted at- [email protected] | https://twitter.com/sankritsays

Related News

Outlook of Automated Immunoassay Analyzers Market status and development trends reviewed in new report

Published Date: 2019-05-24         Author: Rahul Sankrityayan

Automated Immunoassay Analyzers Market size is set to exceed USD 25.0 billion by 2024; according to a new research study published by Global Market Insights, Inc. Increase in prevalence of infectious diseases across the globe will drive the growth of automated immunoassay analyzer market. Infectiou... Read More

Worldwide Health Intelligent Virtual Assistant Market forecasts on regional growth, industry players and more

Published Date: 2019-05-24         Author: Rahul Sankrityayan

Health Intelligent Virtual Assistant Market size is set to exceed USD 1.6 billion by 2024; according to a new research report by Global Market Insights. Rising burden of lifestyle diseases coupled with need to lower increasing healthcare cost should boost adoption of health intelligent virtual assis... Read More

Over-the-Counter (OTC) Drugs Market outlook with industry review and forecasts

Published Date: 2019-05-24         Author: Rahul Sankrityayan

Over-the-Counter Drugs Market size is set to exceed USD 185 billion by 2025; according to a new research report by Global Market Insights. Expanding geriatric population base which is highly susceptible to suffer from several diseases such as joint pain will drive global Over-the-Counter drugs mark... Read More

© 2019 Fractovia. All Rights Reserved